ARKG vs. IVV
ARKG (ARK Genomic Revolution Multi-Sector ETF) and IVV (iShares Core S&P 500 ETF) are both exchange-traded funds - ARKG is a Health & Biotech Equities fund actively managed by ARK, while IVV is a S&P 500 fund tracking the S&P 500 Index. ARKG is actively managed, while IVV is passively managed. Over the past 10 years, ARKG returned 7.22%/yr vs 15.54%/yr for IVV. A 0.59 correlation means they provide meaningful diversification when combined. ARKG charges 0.75%/yr vs 0.03%/yr for IVV.
Performance
ARKG vs. IVV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARKG achieves a 17.09% return, which is significantly higher than IVV's 10.85% return. Over the past 10 years, ARKG has underperformed IVV with an annualized return of 7.22%, while IVV has yielded a comparatively higher 15.54% annualized return.
ARKG
- 1D
- -0.24%
- 1M
- 10.92%
- YTD
- 17.09%
- 6M
- 10.02%
- 1Y
- 53.35%
- 3Y*
- 0.67%
- 5Y*
- -15.72%
- 10Y*
- 7.22%
IVV
- 1D
- -0.76%
- 1M
- 4.97%
- YTD
- 10.85%
- 6M
- 10.87%
- 1Y
- 28.00%
- 3Y*
- 22.43%
- 5Y*
- 13.88%
- 10Y*
- 15.54%
ARKG vs. IVV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 17.09% | 23.04% | -28.24% | 16.22% | -53.90% | -33.92% | 180.40% | 44.00% | -1.26% | 46.61% |
IVV iShares Core S&P 500 ETF | 10.85% | 17.85% | 24.93% | 26.31% | -18.16% | 28.76% | 18.40% | 31.07% | -4.49% | 21.75% |
Correlation
The correlation between ARKG and IVV is 0.56, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.56 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.60 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.63 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.60 |
Correlation (All Time) Calculated using the full available price history since Nov 3, 2014 | 0.59 |
The correlation between ARKG and IVV has been stable across timeframes, ranging from 0.56 to 0.63 - a consistent structural relationship.
ARKG vs. IVV - Sectors Allocation Comparison
Sectors
ARKG
IVV
Healthcare
Financial Services
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
ARKG
IVV
Financial Services
ARKG
IVV
Basic Materials
ARKG
-
IVV
Communication Services
ARKG
-
IVV
Consumer Cyclical
ARKG
-
IVV
Consumer Defensive
ARKG
-
IVV
Energy
ARKG
-
IVV
Industrials
ARKG
-
IVV
Real Estate
ARKG
-
IVV
Technology
ARKG
-
IVV
Utilities
ARKG
-
IVV
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKG vs. IVV — Risk / Return Rank
ARKG
IVV
ARKG vs. IVV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and iShares Core S&P 500 ETF (IVV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ARKG | IVV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.08 | ||
| Sortino ratioReturn per unit of downside risk | -1.26 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.43 | -0.21 |
| Calmar ratioReturn relative to maximum drawdown | 1.95 | 3.17 | -1.22 |
| Martin ratioReturn relative to average drawdown | 4.67 | 14.71 | -10.04 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ARKG | IVV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.31 | 2.39 | -1.08 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.35 | 0.83 | -1.17 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.18 | 0.86 | -0.69 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.13 | 0.45 | -0.32 |
Drawdowns
ARKG vs. IVV - Drawdown Comparison
The maximum ARKG drawdown since its inception was -83.59%, which is greater than IVV's maximum drawdown of -55.25%. Use the drawdown chart below to compare losses from any high point for ARKG and IVV.
Loading charts...
Drawdown Indicators
| ARKG | IVV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.59% | -55.25% | -28.34% |
Max Drawdown (1Y)Largest decline over 1 year | -27.51% | -8.89% | -18.62% |
Max Drawdown (3Y)Largest decline over 3 years | -51.96% | -18.75% | -33.21% |
Max Drawdown (5Y)Largest decline over 5 years | -80.18% | -24.53% | -55.65% |
Max Drawdown (10Y)Largest decline over 10 years | -83.59% | -33.90% | -49.69% |
Current DrawdownCurrent decline from peak | -69.65% | -0.76% | -68.89% |
Average DrawdownAverage peak-to-trough decline | -35.87% | -10.78% | -25.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.46% | 1.91% | +9.55% |
Volatility
ARKG vs. IVV - Volatility Comparison
ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 11.90% compared to iShares Core S&P 500 ETF (IVV) at 2.87%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than IVV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARKG | IVV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.90% | 2.87% | +9.03% |
Volatility (6M)Calculated over the trailing 6-month period | 28.77% | 8.90% | +19.87% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.12% | 11.80% | +29.32% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.61% | 16.88% | +28.73% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.12% | 18.05% | +23.07% |
ARKG vs. IVV - Expense Ratio Comparison
ARKG has a 0.75% expense ratio, which is higher than IVV's 0.03% expense ratio.
Dividends
ARKG vs. IVV - Dividend Comparison
ARKG has not paid dividends to shareholders, while IVV's dividend yield for the trailing twelve months is around 1.06%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% | 0.00% | 0.00% |
IVV iShares Core S&P 500 ETF | 1.06% | 1.17% | 1.30% | 1.44% | 1.66% | 1.20% | 1.57% | 1.85% | 2.21% | 1.75% | 2.01% | 2.27% |
Frequently Asked Questions
ARKG and IVV have a correlation of 0.56, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (11.90%) compared to IVV (2.87%). In terms of maximum drawdown, ARKG dropped -83.59% vs IVV's -55.25%.
On 10-year performance, IVV leads with 15.54% vs 7.22% for ARKG. On fees, IVV is cheaper at 0.03% per year. On volatility, IVV has been the lower-risk option at 2.87%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, IVV has performed better with a 15.54% return vs 7.22%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IVV is cheaper with a 0.03% expense ratio, compared with 0.75% for ARKG.
IVV has the higher dividend yield at 1.06%, compared with 0.00% for ARKG.
ARKG is categorized as Health & Biotech Equities, while IVV is S&P 500. They also come from different issuers: ARK and iShares. Their fees differ too: 0.75% for ARKG and 0.03% for IVV.
IVV currently has the higher Sharpe Ratio (2.39 vs 1.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARKG and IVV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer